Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs.
about
Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cellsCirculating biomarkers to monitor cancer progression and treatmentCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaCan circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?Methodological challenges in utilizing miRNAs as circulating biomarkersCerebrospinal fluid MicroRNA profiling using quantitative real time PCRNormalization of circulating microRNA expression data obtained by quantitative real-time RT-PCRA six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.MicroRNA profiling in gingival crevicular fluid of periodontitis-a pilot studyNoninvasive micromarkersPlasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 monthsPlasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds.Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cellsA novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity.Circulating RNA molecules as biomarkers in liver disease.Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis BProfiling of circulating microRNAs after a bout of acute resistance exercise in humansPerformance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines.Influence of plasma processing on recovery and analysis of circulating nucleic acids.Profile of cerebrospinal microRNAs in fibromyalgia.Optimized microRNA purification from TRIzol-treated plasma.Genome-wide identification of microRNA expression quantitative trait loci.Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.An improved method for detecting circulating microRNAs with S-Poly(T) Plus real-time PCR.Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling.Serum microRNAs as biomarkers for recurrence in melanoma.Sensitive PCR-based quantitation of cell-free circulating microRNAsProbable impact of age and hypoxia on proliferation and microRNA expression profile of bone marrow-derived human mesenchymal stem cellsObesity Associated Modulation of miRNA and Co-Regulated Target Transcripts in Human Adipose Tissue of Non-Diabetic SubjectsmiRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in childrenIdentification of reference genes for circulating microRNA analysis in colorectal cancer.Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR.A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.A panel of microRNA signature in serum for colorectal cancer diagnosis.miRNAs and long noncoding RNAs as biomarkers in human diseases.MicroRNA biomarkers in glioblastoma.miRNA as markers for the diagnostic screening of colon cancer.The validity of circulating microRNAs in oncology: five years of challenges and contradictions.Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer.
P2860
Q24288969-46DDE377-CE68-4AB5-9CA2-D9EDD373CC8CQ26745985-66940427-2263-472F-9251-B06055C9D26DQ26767346-FFB64728-F69C-47E2-9ACE-BAAF6AECC153Q26775704-BAE409B9-52B3-4234-B5B0-65795B4B16B8Q27027950-F3988704-0701-4133-BFDF-B138A708A8FBQ28655943-26FD02F9-21C5-4D1B-A2FC-07C0F2C50B8BQ30984776-FF973491-6719-4F34-9370-07A871CA096DQ33798418-A3D20FA3-4E3F-4C1F-9B15-97D5454BDA91Q33862959-6B826CD9-F0D9-4D98-A5B7-D3C7FE427124Q34111606-D2DAD382-0D61-4E6F-96E9-68EAB87141DEQ34272358-B2F7243B-E87E-4264-AAF5-2779072B1A50Q34324137-4A45A090-ADF5-4313-BF68-1351E1793668Q34415158-295C6DB3-E9FB-46ED-B148-54638975E478Q34477363-8FC8B4C4-3044-41C0-8371-EFE4007E8DAFQ34486635-A6B7CC10-9675-4562-9442-11D80BBADD57Q34613446-C49AEAF5-CD09-4A5A-8353-B22FF27D1931Q34907358-B2EC6D61-D38F-4F8A-95E4-6C0301055969Q35014565-A609AA2C-4231-42B8-ACEA-265AA7909952Q35035846-12F505B5-0AEF-41CF-816B-9E5DE949F586Q35036703-704366BE-5455-4288-9585-B75E5B1DBFB4Q35128033-9DAABBEB-80D8-40C9-B016-76FB1F3D6A0FQ35206403-261798E8-5B77-4504-8DC2-8E534C79D691Q35710429-13E070C4-AE16-4D1B-891E-A2591FA8602BQ36149974-4C96B155-A340-46C3-B3F0-7873643BE105Q36151674-C70CEF0E-38DC-4B70-8C4B-60AF5F9A004FQ36341127-6C4912E6-941D-4A56-8A19-E855BD32974DQ36428830-CFD0D2AF-2FF0-4A35-AE5A-9E49DFE0B2C0Q36469522-C7F22A0D-2FD3-4B8A-9D2E-AF4B8E0F2969Q36542811-5AEFCAC3-8E19-4245-ADBE-DCC3879F3B33Q37218300-94910CE5-34D9-4DF4-926E-78C006E62C45Q37296897-F53BBD47-AF10-49DA-83DC-E756B2DB4A03Q37349084-5A27C545-AB89-484C-8185-D3156523FAACQ37648480-599E85A4-01DA-462F-B7FA-D4A6174657DAQ37701630-2CE33738-7506-43A0-AA68-19D24C3BF6F1Q37725573-21A83EF1-4EF7-4337-9C01-E59AB84E7701Q38088011-EBD9EA38-45AA-4C17-81FA-1D4673E7EBC8Q38108768-C5EF50DC-8C09-48FB-98A9-025632F97734Q38192078-AAA1F808-BB85-4AD2-AA6C-79E3332942E4Q38198366-3D083C8B-86EB-4FDA-AA96-EA58100C4A0FQ38294147-71679233-099C-4536-B23A-0D4D994D70F9
P2860
Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@ast
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@en
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@nl
type
label
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@ast
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@en
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@nl
prefLabel
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@ast
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@en
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@nl
P2093
P2860
P356
P1433
P1476
Evaluation of two commercial g ...... ction of less abundant miRNAs.
@en
P2093
Mads H Rasmussen
Marie S Ostenfeld
Philippe Lamy
Steffen G Jensen
Torben F Orntoft
P2860
P356
10.1186/1471-2164-12-435
P407
P577
2011-08-26T00:00:00Z